台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    160.0
  • 漲跌
    ▼1.0
  • 漲幅
    -0.62%
  • 成交量
    21
  • 產業
    上櫃 生技醫療類股▲2.09%
  • 67人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-凱基-科園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-科園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/0900.001159.00160.00-110-9.80%
2024/04/011156.0000.00158.001109.74%
2023/06/3000.003172.67172.00-351-5.78%
2023/06/123172.8300.00171.503535.60%
2023/06/0600.002187.50188.50-253-3.76%
2023/05/3000.001187.50186.50-161-1.62%
2023/05/291185.0000.00186.001611.62%
2023/05/262184.5000.00185.002613.23%
2023/05/1700.002185.00185.50-260-3.29%
2023/05/162182.0000.00180.502603.29%
2023/05/0400.003184.50185.00-358-5.17%
2023/05/033179.1700.00183.503585.17%
2023/01/1000.001156.50154.00-168-1.46%
2022/12/051154.0000.00151.001611.64%
2022/08/2300.001166.50171.00-183-1.19%
2022/08/151154.0000.00154.001651.52%
2022/05/2700.001126.50127.50-136-2.72%
2022/05/1100.001125.00126.00-143-2.28%
2022/04/281131.5000.00132.001611.61%
2022/02/071130.5000.00131.001621.60%
2021/11/1700.001103.50104.50-121-4.63%
2021/07/211101.0000.00101.501382.61%
2021/05/1700.00199.70100.50-142-2.33%
2021/05/141103.0000.00103.001432.32%
2021/01/2800.00299.60101.00-250-3.97%
2021/01/2200.000.498.8098.80-0.445-0.77%
2021/01/2100.000.1100.00100.00-0.144-0.18%
2021/01/201100.000.1101.00100.500.9412.29%
2021/01/140.1106.501107.00107.00-0.937-2.40%
2021/01/130.1108.0000.00108.500.1360.25%
2021/01/110.3110.0000.00108.500.3350.86%
2020/08/1800.001130.00130.00-1109-0.91%
2020/06/0500.000.3115.50115.50-0.373-0.34%
2020/05/0400.001106.00105.50-195-1.05%
2020/04/301102.5000.00104.501951.05%
2020/02/212116.5000.00116.002653.05%
2019/11/2200.002122.50122.50-264-3.10%
2019/11/122116.0000.00116.002593.36%
2019/11/0800.001124.00123.00-158-1.72%
2019/10/171125.5000.00126.501881.13%
2018/04/251160.001166.00166.0003710.00%
2018/04/2400.001164.50161.50-1374-0.27%
2018/04/234177.754178.50172.0003640.00%
2018/04/2000.002170.00173.00-2342-0.58%
2018/04/1000.001158.00155.00-1332-0.30%
2018/04/0900.001168.00168.00-1322-0.31%
2018/04/031171.0000.00167.5013150.32%
2018/03/311153.5000.00153.5012880.35%
2018/03/0700.001141.00140.50-1292-0.34%
2018/03/061140.0000.00139.5012970.34%
2018/03/0500.001142.00140.50-1306-0.33%
2018/03/021141.0000.00141.0013130.32%
2018/02/061166.001161.00162.5003070.00%
2018/01/192176.5000.00174.0023100.64%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章